Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Quest Diagnostics (DGX)

Quest Diagnostics issues $500 million of 5.000% senior notes due 2036

Neutral Impact 3 of 5 financing Written later

Quest Diagnostics issued $500 million in aggregate principal of 5.000% senior notes due June 30, 2036, on May 6, 2026, under its existing 2001 indenture as supplemented. The notes are senior unsecured obligations that rank equally with the company's other senior unsecured debt, and the filing describes covenants limiting certain liens, sale and leaseback transactions, and mergers or asset transfers.

Key points

  • Principal amount: $500 million; interest rate 5.000%, paid June 30 and December 30, first payment December 30, 2026
  • Maturity: June 30, 2036; no sinking fund
  • Change of control triggering event requires an offer to repurchase at 101% of principal plus accrued interest
  • Exhibit 5.1 legality opinion from Allen Overy Shearman Sterling US LLP filed with the report

The filing

CompanyQuest Diagnostics (DGX)
Form8-K, current report
Filed with the SECMay 8, 2026, 4:15 PM ET
Accession number0001104659-26-057938

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.